Explain this page
Arphra AIPlain-English read on Xylem Inc.’s valuationIncome statement
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E | 2029E |
|---|---|---|---|---|---|---|---|---|---|
| Revenue & profit | |||||||||
| Revenue | $5.2B | $5.52B | $7.36B | $8.56B | $9.04B | $9.25B | $9.61B | $10.11B | $10.68B |
| Cost of revenue | $3.22B | $3.44B | $4.65B | $5.35B | $5.56B | $5.93B | $6.01B | $6.3B | $6.64B |
| Gross profit | $1.98B | $2.08B | $2.72B | $3.21B | $3.48B | $3.39B | $3.58B | $3.73B | $3.94B |
| Gross margin | +38.02% | +37.74% | +36.90% | +37.51% | +38.46% | +36.61% | +37.26% | +36.89% | +36.91% |
| Operating | |||||||||
| Research & development | $204M | $206M | $232M | $230M | $226M | $262.35M | $269.62M | $286.82M | $300.97M |
| Selling, general & administrative | $1.18B | $1.37B | $1.76B | $1.91B | $1.92B | $2.02B | $2.15B | $2.21B | $2.43B |
| Total operating expenses | $1.39B | $1.46B | $2.07B | $2.2B | $2.25B | $2.43B | $2.5B | $2.66B | $2.87B |
| Operating income | $585M | $622M | $652M | $1.01B | $1.22B | $1.03B | $1.08B | $1.16B | $1.24B |
| Operating margin | +11.26% | +11.26% | +8.85% | +11.78% | +13.54% | +11.15% | +11.22% | +11.48% | +11.65% |
| EBITDA | $832M | $726M | $1.12B | $1.69B | $1.79B | $1.64B | $1.75B | $1.82B | $1.9B |
| EBIT | $587M | $490M | $684M | $1.13B | $1.21B | $1.1B | $1.15B | $1.18B | $1.27B |
| Below the line | |||||||||
| Interest expense | $76M | $50M | $49M | $44M | $29M | $47.54M | $46.88M | $51.56M | $52.99M |
| Interest income | $7M | $16M | $28M | $28M | $0 | $21.38M | $22.69M | $23.65M | $24.71M |
| Other income / expense | -$74M | -$182M | -$17M | $78M | -$42M | — | — | — | — |
| Pre-tax income | $511M | $440M | $635M | $1.09B | $1.18B | $1.06B | $1.09B | $1.14B | $1.19B |
| Income tax expense | $84M | $85M | $26M | $197M | $231M | $145.66M | $149.96M | $156.9M | $165.79M |
| Earnings | |||||||||
| Net income | $427M | $355M | $609M | $890M | $957M | $906.81M | $929.06M | $965.26M | $1.02B |
| Net income · continuing ops | $427M | $355M | $609M | $890M | $950M | $923.81M | $946.53M | $1.01B | $1.06B |
| Net margin | +8.22% | +6.43% | +8.27% | +10.39% | +10.59% | +9.80% | +9.67% | +9.55% | +9.58% |
| EPS · basic | $2.37 | $1.97 | $2.81 | $3.67 | $3.93 | $5.56 | $6.04 | $6.82 | $7.91 |
| EPS · diluted | $2.35 | $1.96 | $2.79 | $3.65 | $3.92 | $5.53 | $6.08 | $6.72 | $7.78 |
| EPS · low estimate | — | — | — | — | — | $5.42 | $5.73 | $6.38 | $7.42 |
| EPS · high estimate | — | — | — | — | — | $5.62 | $6.37 | $7.13 | $7.92 |
| Shares · basic | 180.25M | 180.22M | 216.98M | 242.6M | 243.4M | 242.32M | 242.43M | 241.45M | 243.84M |
| Shares · diluted | 181.53M | 180.98M | 218.18M | 243.5M | 244M | 245.63M | 244.66M | 245.3M | 241.73M |
| Coverage | |||||||||
| Analysts (revenue) | — | — | — | — | — | 17 | 17 | 10 | 5 |
| Analysts (EPS) | — | — | — | — | — | 15 | 15 | 5 | 1 |
Coverage notes. Historical figures come’s as-reported income statements / balance sheets / cash flows in our data warehouse. Forecast columns (italicised, faint accent tint) carry vendor-supplied numbers where available (revenue + EPS consensus) and ratio-derived values for every other line. Margins / ratios are the trailing-3y average from history applied to the forecast revenue; values are clamped to enforce P&L identity (gross ≥ operating, EBITDA ≥ operating, net ≤ operating) and balance-sheet identity (assets = liabilities + equity by construction). Cash-flow FCF reconciles to OCF + CapEx. USD conversion uses the period-end close of the issuer's reported/USD pair from forex_prices_daily; share counts stay unconverted.
Financials
Full income statement, balance sheet, and cash-flow history is included with Pro.
Upgrade to Pro